David S. Morris, MD, FACS, presented “Implementation of Markers in Clinical Practice” during the 33rd International Prostate Cancer Update on January 24, 2023, in Vail, Colorado.

How to cite: Morris, David S. “Implementation of Markers in Clinical Practice.” January 24, 2023. Accessed Jun 2024. https://grandroundsinurology.com/radioligand-therapy-in-prostate-cancer/

Implementation of Markers in Clinical Practice – Summary

David S. Morris, MD, FACS, discusses implementation of various markers in screening, diagnosing, and treating prostate cancer in community practice. He discusses the G-Minor (Genomics in Michigan ImpactiNg Observation or Radiation) trial and a retrospective analysis of the STAMPEDE (Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy) trial, wherein certain markers were able to predict both metastasis-free survival and overall survival.

About The 33rd Annual International Prostate Cancer Update:

The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. It is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer. The 33rd iteration of the meeting occurred January 22-25, 2023 in Vail, Colorado. To view more educational presentations from IPCU 33, visit our collection page.